Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
Pediatric Rheumatology, 01/27/09
Brogan RJ et al. - Case report describes an 8 year old boy with IVIG resistant Kawasaki disease complicated by severe bilateral coronary artery aneurysms successfully treated with infliximab, a monoclonal antibody against tumour necrosis factor alpha.
Related Articles
Comparing the Autoantibody Levels and Clinical Efficacy of Double Filtration Plasmapheresis, Immunoadsorption, and Intravenous Immunoglobulin for the Treatment of Late-onset Myasthenia Gravis
Therapeutic Apheresis and Dialysis, 11/04/09
Relevance Score: 65%
A High Dose of Intravenous Immunoglobulin Increases CD94 Expression on Natural Killer Cells in Women with Recurrent Spontaneous Abortion
American Journal of Reproductive Immunology, 10/26/09
Relevance Score: 65%
Immediate Relief of Mycoplasma pneumoniae Encephalitis Symptoms After Intravenous Immunoglobulin
Pediatric Neurology, 10/20/09
Relevance Score: 65%
Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 64%
In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations
Vox Sanguinis, 10/16/09
Relevance Score: 64%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Interferon-[alpha] mediates suppression of C-reactive protein: Explanation for muted C-reactive protein response in lupus flares?
Arthritis & Rheumatism, 12/06/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/06/09
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Journal of Dermatological Treatment , 12/04/09
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of bisphosphonates in the treatment of pediatric osteoporosis
International Journal of Clinical Rheumatology, 12/04/09
Association of juvenile idiopathic arhrtitis and functional constipation
International Journal of Clinical Rheumatology, 12/04/09
Systemic vasculitis in childhood
Current Rheumatology Reports, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


